MLMIC Insurance Company is committed to offering choices to policyholders, and it is making a new policy discount available to dentists — Waiver of Consent to Settle, which will provide a 5% reduction in annual policy premiums beginning November 1, 2022.*

Valued current MLMIC dental policyholders can choose to add the discount upon renewal of their MLMIC policy. Those with a renewal date on or after November 1, 2022, will receive notice regarding the availability of the new Waiver of Consent to Settle option and the form needed to record their choice. MLMIC must receive the completed Waiver of Consent to Settle form by the required deadline to ensure the policyholder’s choice is reflected on the renewal policy.

New applicants can choose to have the 5% premium discount for waiving their right to consent to settle on the last page of their application for coverage submitted as of 11/1/2022.

“Under the existing MLMIC policy structure, the decision to settle a claim or take it to trial lies solely in the hands of our valued policyholders and that choice will continue. We know it is greatly empowering to policyholders to have the final say in the resolution of a claim,” said Nicole Lombardo, MLMIC senior underwriting manager.  

“But we understand that policyholders may also appreciate the savings opportunity now available with the new Waiver of Consent option. MLMIC prides itself on vigorously defending the interests of our policyholders and that will never change,” Ms. Lombardo added.

If you have any questions, please contact the MLMIC dental team at (800) 416-1241 or at Dentists can apply for coverage online on our rapid application.

*Waiver of Consent to Settle discount will be applied upon renewal for existing MLMIC Insurance Company policyholders with renewal dates on or after November 1, 2022, who choose this option and return the Waiver of Consent form. New applicants can elect to apply this discount on the application for coverage, and it will be available upon issuance of a new MLMIC Insurance Company policy.